CD82 and metabolic dysfunction-associated steatotic liver disease: In summary, decreased miR-193b expression and the presence of a variant in CD82 gene might result in insulin resistance, dysregulation of adipokines, and an increase in hepatic fat content, which might all cause NAFLD and activate biological pathways leading to HCC, colorectal cancer, and heart failure.